CMS Cannabinoid Coverage: Experts Warn of Safety Risks
The Controversy Surrounding Federal Cannabinoid Reimbursement The Impending Policy Shift The Centers for Medicare & Medicaid Services (CMS) is nearing the implementation of a landmark federal cannabinoid reimbursement program, marking a seismic shift in how the U.S. healthcare system interacts with cannabis-derived therapies. While proponents argue this move is essential for expanding patient access to…

